@megtirrell@DarioAmodei It increases productivity ATM. It’s not overly competent in complex biology. Simple repetitive tasks suit it best now. Also too many guard rails to even function at a rudimentary level at times. Eg. Try & discuss anything with respect to a coronavirus and protease use…
@Unusual_Times@yunlong_cao From the growth in various cells it looks more like changes in and around the FCS that optimise its cleavage of S1/S2 on viral particles. We see this as depletion of Spike from viral particles when expanding it in Vero based cell lines.
C’est avec une profonde tristesse que nous apprenons le décès de la Dre Marie-France Shogogo, jeune médecin décédée des suites d’Ebola à Beni.
Cette perte douloureuse nous rappelle une urgence absolue : protéger ceux qui nous protègent.
Africa CDC présente ses sincères condoléances à sa famille, à ses collègues et à toute la communauté médicale. Que son âme repose en paix.
Gutted to see our national science organisation keep losing talented scientists & expertise built up over decades.
A further 86 FTE positions cut in the lead up to Christmas, is devastating for those impacted, our community + sovereign capability.
Short-term thinking at its worst. We need to ⬆️ our scientific capacity & R&D spend to confront the challenges facing us.
https://t.co/QmeaxKrvhJ
Join me in calling for the government to save our CSIRO: https://t.co/aF3m37QOO9
@envidreamz Best place to look at that would be Papua New Guinea. https://t.co/fZW5h682q2
That and other similar countries with low vaccine uptake. Important question but one hard to resolve based on apathy and lack of funding in general.
@OccupyNN@Tuliodna There are many exceptions in any methodology and primarily why we help many clinicians with vulnerable populations (cancer, MS, immunocompromised). Most of time we do this in kind as it’s important to those at risk (but may not attract the funding it deserves).
@Nucleocapsoid@SGriffin_Lab Reminds me of HIV. Buried in a cloak of sugar and poorly immunogenic.. well gp120 is. Probably another consequence of a chronic infection.
@stevenemassey Viral replication is the sum of parts. The FCS gates protease use for entry and then promotes replication during cell-cell spread. For SARS CoV-2 the FCS is regulated very differently during both of these processes. Cell-cell spread is often seen as cell-cell fusion in vitro.
Stronger coordination across financing mechanisms and institutions is essential to ensuring timely access to medical countermeasures.
At #WBGMeetings in Bangkok, the @Pandemic_Fund’s Executive Head, @PriyaBasu2017, highlighted that effective access to medical countermeasures begins long before a crisis. Sustained investment in surveillance, laboratories, diagnostics, the health workforce and community-based delivery systems enables countries to detect threats early, identify the products needed and deliver them effectively to communities.
Thanks to WHO, the JFHTF Secretariat, France and the UK for convening this important dialogue.